#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cholangiosarcoma Cardiomyopathy Shprintzen-Goldberg syndrome Penile cancer Neuropathic arthropathy Alveolar proteinosis Osteomyelitis Undifferentiated sarcoma Mantle cell lymphoma stage III Restless legs syndrome Adrenoleukodystrophy Rhabdoid tumour Lip and/or oral cavity cancer Chemical burn Obesity More trials…

    Learn about Rare Diseases

    Hepatoblastoma – Treatment Retinoblastoma – Diagnostics Angiosarcoma metastatic Acute respiratory distress syndrome – Trials in Disease Aicardi-Goutieres syndrome Nephrotic syndrome – Basic Information Malignant fibrous histiocytoma – Trials in Disease Friedreich’s ataxia Synovial sarcoma metastatic – Treatment Ewing’s sarcoma metastatic – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ivonescimab Troriluzole Ezabenlimab Mps-213 Ozanimod Hydrochloride Avacincaptad Pegol Isoleucine Ibrutinib Nepafenac Vigabatrin AGANIRSEN Fasudil Hydrochloride Prednisolone Acetate CEFTAROLINE FOSAMIL Rilpivirine Phenobarbital Chloropyramine Hydrochloride Abc-23A-116 Tislelizumab Fipaxalparant More therapies…

    Learn about Your Condition

    Oropharyngeal cancer recurrent Oesophagectomy BRAF gene mutation Hypopituitarism Burkitt's lymphoma Cartilage injury Systemic mastocytosis Diabetic retinopathy Immune system disorder Bipolar disorder Obstructive airways disorder Intestinal obstruction Tuberous sclerosis complex Rosai-Dorfman syndrome Neurofibrosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Belatacept Dose Reduction Safety in Kidney Transplant Recipients with a Well-Matched Donor

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Belatacept
    Austria

  • Neoadjuvant Sacituzumab Govitecan and Pembrolizumab for Patients with Clinical Stage II-III Triple-Negative Early Breast Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer stage III
    • Breast cancer female
    • Breast cancer male
    Investigated Drugs:
    • Sacituzumab Govitecan
    • Pembrolizumab
    Germany

  • Letrozole During IVF/ICSI for Women with Endometriosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • Letrozole
    Belgium

  • Verteporfin for Scar Prevention in Patients After Surgical Wounds

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • VERTEPORFIN
    • Saline
    Denmark

  • Dermatophagoides farinae, Dermatophagoides pteronyssinus, and Lepidoglyphus destructor Immunotherapy for Allergic Rhinitis and Rhinoconjunctivitis in Patients With or Without Mild Asthma

    Not yet recruiting

    3 1
    Investigated Drugs:
    • ALLERGEN EXTRACTS
    • Dermatophagoides Farinae Allergoid, Glutaraldehyde-Modified
    • Dermatophagoides Pteronyssinus Allergoid, Glutaraldehyde-Modified
    Spain

  • Maribavir for High Epstein-Barr Virus Infection in Young Adult Kidney Transplant Recipients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Epstein-Barr virus infection
    Investigated Drugs:
    • Maribavir
    Spain
Previous Page
1 … 710 711 712 713 714 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!